SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-241906
Filing Date
2021-08-10
Accepted
2021-08-10 16:41:05
Documents
13
Period of Report
2021-08-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d180939d8k.htm   iXBRL 8-K 31081
  Complete submission text file 0001193125-21-241906.txt   197423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210806.xsd EX-101.SCH 3965
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210806_def.xml EX-101.DEF 14269
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210806_lab.xml EX-101.LAB 23649
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210806_pre.xml EX-101.PRE 15302
6 EXTRACTED XBRL INSTANCE DOCUMENT d180939d8k_htm.xml XML 6606
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 211160542
SIC: 2834 Pharmaceutical Preparations